NCT05822479Completed
Laparoscopic Sleeve Gastrectomy Surgery and External Oblique Intercostal Block
Bilateral Ultrasound-guided External Oblique Intercostal Block for Postoperative Analgesia in Patients Undergoing Laparoscopic Sleeve Gastrectomy Surgery: A Prospective Randomized Controlled Study
Source: ClinicalTrials.gov · Last updated 3 Jul 2024
Brief summary (registry, in English)
In obese patients, adequate pain relief in the postoperative period is an important parameter that affects patient comfort and hospital stay. Increasing patient comfort and recovery quality can be achieved by avoiding undesirable effects such as nausea, vomiting, and analgesia. This study aimed to evaluate the impact of the external oblique intercostal block postoperative acute pain scores and opioid consumption in the first 24 hours after laparoscopic sleeve gastrectomy surgery.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 60 (actual)
- First submitted
- 10 Apr 2023
- Start date
- 20 Apr 2023
- Primary completion date
- 20 Dec 2023
- Lead sponsor
- Ondokuz Mayıs University
- Diseases
- Obesity
- NCT number
- NCT05822479
What you commit to
- Study type: Interventional
- Participants enrolled: 60
- From 20 Apr 2023 to the primary completion date, 20 Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients with a history of chronic pain syndromes or receiving chronic pain treatment and a history of opioid use for more than four weeks in the preoperative period
- Patients who need intensive care unit after surgery
Other illness
- Patients with drug allergies (Opioids, NSAIDs, local anesthetics)
- Patients with neuro-psychiatric disease, cognitive impairment, inability to communicate, or a history of drug addiction
- Presence of any systemic infection or at the injection site
- Patients with significant cardiovascular, hepatic, renal or endocrine disorders
- Patients using continuous positive airway pressure device due to obstructive sleep apnea syndrome (OSAS) (symptoms detected by polysomnography and apnea-hypopnea index (AHI) \>5/hour)
- Patients with chronic obstructive pulmonary disease
Lab values
- Patients taking anticoagulants or having any bleeding disorder (Coagulopathy, International Normalized Ratio (INR) value not within normal limits, thrombocytopenia or platelet dysfunction)
Other
- Patients who do not consent/do not want to participate
Who the study is looking for
- Age between18-65 years
- American Society of Anesthesiology score II-III
- Body mass index (BMI) \> 35 kg/m2
- Patients who will sign the informed consent form
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ondokuz Mayis Üniversitesi Coordinator of this site? Confirm its status | Samsun | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.